The International Space Station has a unique and extreme microbial and chemical environment driven by use patterns
- PMID: 40020666
- PMCID: PMC12068931
- DOI: 10.1016/j.cell.2025.01.039
The International Space Station has a unique and extreme microbial and chemical environment driven by use patterns
Abstract
Space habitation provides unique challenges in built environments isolated from Earth. We produced a 3D map of the microbes and metabolites throughout the United States Orbital Segment (USOS) of the International Space Station (ISS) with 803 samples collected during space flight, including controls. We find that the use of each of the nine sampled modules within the ISS strongly drives the microbiology and chemistry of the habitat. Relating the microbiology to other Earth habitats, we find that, as with human microbiota, built environment microbiota also align naturally along an axis of industrialization, with the ISS providing an extreme example of an industrialized environment. We demonstrate the utility of culture-independent sequencing for microbial risk monitoring, especially as the location of sequencing moves to space. The resulting resource of chemistry and microbiology in the space-built environment will guide long-term efforts to maintain human health in space for longer durations.
Keywords: 3D mapping; International Space Station; built environment; culture independent; extraterrestrial habitat; indoor environment; metabolome; metabolomics; microbiome; surface swab.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests R.K. is a scientific advisory board member and consultant for BiomeSense, Inc., and has equity and receives income. He is a scientific advisory board member and has equity in GenCirq. He is a consultant and scientific advisory board member for DayTwo and receives income. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. He is a co-founder of Micronoma, has equity, and is a scientific advisory board member. D.M. is a consultant for and has equity in BiomeSense, Inc. The terms of these arrangements have been reviewed and approved by the University of California, San Diego, in accordance with its conflict-of-interest policies. P.C.D. is the scientific advisor to and holds equity in Sirenas and Cybele Microbiome and is scientific co-founder and scientific advisor of and has equity in Ometa Labs, Arome, and Enveda (with approval by UC San Diego). C.M. is the founder of, has equity in, and receives income from Leaven Foods Inc.
References
-
- Hummerick ME, Khodadad CLM, Dixit AR, Spencer LE, Maldonado-Vasquez GJ, Gooden JL, Spern CJ, Fischer JA, Dufour N, Wheeler RM, et al. (2021). Spatial Characterization of Microbial Communities on Multi-Species Leafy Greens Grown Simultaneously in the Vegetable Production Systems on the International Space Station. Life 11. 10.3390/life11101060. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
